Showing results (1801-1810 of 4,190) with videos related to
Sort By:
Pageof 419
International Journal of Chronic Obstructive Pulmonary Disease|November 30, 2016
Community-based exercise training for people with chronic respiratory and chronic cardiac disease: a mixed-methods evaluationRenae J McNamara, Zoe J McKeough, Laura R Mo, et al.International Journal of Chronic Obstructive Pulmonary Disease|November 25, 2016
COPD care delivery pathways in five European Union countries: mapping and health care professionals' perceptionsReem Kayyali, Bassel Odeh, Inéz Frerichs, et al.International Journal of Chronic Obstructive Pulmonary Disease|October 8, 2016
Can resistive breathing injure the lung? Implications for COPD exacerbationsTheodoros Vassilakopoulos, Dimitrios ToumpanakisInternational Journal of Chronic Obstructive Pulmonary Disease|December 7, 2016
Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trialPinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun, et al.International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2016
Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPDBenoit Borel, Courtney A Wilkinson-Maitland, Alan Hamilton, et al.International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2016
Computer quantification of "angle of collapse" on maximum expiratory flow volume curve for diagnosing asthma-COPD overlap syndromeWei Wang, Mengshuang Xie, Shuang Dou, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 14, 2014
Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary diseaseKoichi Nishimura, Takashi Nishimura, Katsuya Onishi, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 6, 2014
Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 studyWalter Vincken, Joseph Aumann, Hungta Chen, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 6, 2014
Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPDGaetano Caramori, Kian Fan Chung, Ian M AdcockInternational Journal of Chronic Obstructive Pulmonary Disease|November 15, 2018
Intra- and inter-rater reproducibility of the 6-minute walk test and the 30-second sit-to-stand test in patients with severe and very severe COPDHenrik Hansen, Nina Beyer, Anne Frølich, et al.Pageof 419